Dr. Syedah Fauzia Fatima Gilani
is working as
Assistant Professor
in the
NUST School of Health Sciences
. Dr. Syedah Fauzia Fatima Gilani
has a PhD in
their field
. Dr. Syedah Fauzia Fatima Gilani
has published
6
research articles & conference papers having a citation count of
6
, carried out
0
projects and filed
0
intellectual property.
National University of Medical Sciences (NUMS) ,Rawalpindi
,
Pakistan
MBBS
Medicine and Surgery
2003-
2007
NUST, Islamabad
,
Pakistan
Experience
Assistant Professor
2025- Present
NUST School of Health Sciences
, NUST
Senior Demonstrator
2023-
2023
NUST School of Health Sciences
, NUST
PG Trainee
2021-
2023
Army Medical College
,
H2RP+968, Abid Majeed Rd, Rawalpindi
,
Demonstrator
2018-
2020
Aziz Fatima Medical and Dental College
,
Old Ghafoor Bashir Building, Faisal Town, Canal Expy, Faisal Town Canal Road, Faisalabad
,
Demonstrator
2016-
2017
Rawal Institute of Health Sciences
,
Rawal InstAlmehrban Road, Madina Town, Tarlai Kalan, Islamabad.
,
Clinical PG Trainee
2009-
2013
Shalamar Institute of Health Sciences
,
Shalimar link road, Lahore Pakistan
,
Awards
Memberships
No project records found for this faculty member
6
Research Articles
0
Conference Proceedings
0
Books
0
Book Chapters
0
Editorial Activities
Efficacy and Cost-Effectiveness, Comparison of 7-Days Vonoprazan Versus 14-Days Esomeprazole Based Triple Therapies for Treating Helicobacter Pylori Infection in Pakistani Population: A Randomized Clinical Trial2023
FA
Farzana Waqar
(National University of Medical Sciences (NUMS))
MU
Mudassar Noor
(National University of Medical Sciences (NUMS))
KU
Kulsoom Farhat
(National University of Medical Sciences (NUMS))
SH
Shabana Ali
(National University of Medical Sciences (NUMS))
Journal: Journal of Ayub Medical College, Volume 35(3), Article Number 442-446
Impact Factor: N/ACitations: 2Quartile: N/A
Therapeutic efficacy and drug safety comparison of one-week Vonoprazan triple therapy with two-weeks Esomeprazole triple therapy in Helicobacter pylori infection: Findings from a single-centre randomized clinical trial in population of Pakistan.2024